Clinical Trial Update: An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder [Phase 3]

View source ↗

Summary

This clinical-trial update reports the completion of a Phase 3 eight-week study evaluating the combination of Saredutant and Escitalopram for Major Depressive D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Saredutant (saredutant)

Snippet

Sponsor: Sanofi | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED